7-13931612-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004956.5(ETV1):āc.692A>Gā(p.Tyr231Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000205 in 1,461,710 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000021 ( 0 hom. )
Consequence
ETV1
NM_004956.5 missense
NM_004956.5 missense
Scores
3
11
5
Clinical Significance
Conservation
PhyloP100: 4.55
Genes affected
ETV1 (HGNC:3490): (ETS variant transcription factor 1) This gene encodes a member of the ETS (E twenty-six) family of transcription factors. The ETS proteins regulate many target genes that modulate biological processes like cell growth, angiogenesis, migration, proliferation and differentiation. All ETS proteins contain an ETS DNA-binding domain that binds to DNA sequences containing the consensus 5'-CGGA[AT]-3'. The protein encoded by this gene contains a conserved short acidic transactivation domain (TAD) in the N-terminal region, in addition to the ETS DNA-binding domain in the C-terminal region. This gene is involved in chromosomal translocations, which result in multiple fusion proteins including EWS-ETV1 in Ewing sarcoma and at least 10 ETV1 partners (see PMID: 19657377, Table 1) in prostate cancer. In addition to chromosomal rearrangement, this gene is overexpressed in prostate cancer, melanoma and gastrointestinal stromal tumor. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETV1 | NM_004956.5 | c.692A>G | p.Tyr231Cys | missense_variant | 9/14 | ENST00000430479.6 | NP_004947.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETV1 | ENST00000430479.6 | c.692A>G | p.Tyr231Cys | missense_variant | 9/14 | 1 | NM_004956.5 | ENSP00000405327.1 | ||
ETV1 | ENST00000405358.8 | c.734A>G | p.Tyr245Cys | missense_variant | 7/12 | 5 | ENSP00000384085.4 | |||
ETV1 | ENST00000405218.6 | c.692A>G | p.Tyr231Cys | missense_variant | 8/13 | 5 | ENSP00000385551.2 | |||
ETV1 | ENST00000403685.5 | c.638A>G | p.Tyr213Cys | missense_variant | 7/12 | 1 | ENSP00000385686.1 | |||
ETV1 | ENST00000403527.6 | c.572A>G | p.Tyr191Cys | missense_variant | 5/10 | 1 | ENSP00000384138.1 | |||
ETV1 | ENST00000438956.6 | c.518A>G | p.Tyr173Cys | missense_variant | 4/9 | 1 | ENSP00000393078.2 | |||
ETV1 | ENST00000443137.5 | n.692A>G | non_coding_transcript_exon_variant | 9/15 | 2 | ENSP00000413836.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461710Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727136
GnomAD4 exome
AF:
AC:
3
AN:
1461710
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
727136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.692A>G (p.Y231C) alteration is located in exon 9 (coding exon 7) of the ETV1 gene. This alteration results from a A to G substitution at nucleotide position 692, causing the tyrosine (Y) at amino acid position 231 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.;.;.;.;.;T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;D;D;D;D;D;D;.;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;.;M;.;.;M;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
D;D;T;D;D;D;D;D;D;.;D
Polyphen
D;.;.;D;.;D;.;D;D;.;.
Vest4
MutPred
0.58
.;.;.;.;.;Loss of phosphorylation at Y245 (P = 0.0047);.;.;.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.